Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis

Completed · Phase 3

Conditions studied: Osteoarthritis of the Knee

In brief

The study will identify the efficacy of Apitox, purified honeybee toxin, in 330 patients with diagnosed osteoarthritis of the knee. The subjects will be evaluated for relief of pain using Western Ontario and McMaster Osteoarthritis Index (WOMAC) and Physician and Patient Global Assessments and primary efficacy measure of relief of pain and inflammation over a 12 week treatment period after randomization into the trial. Secondary efficacy is improvement of mobility Treatment effect will be compared in a 2-1 Apitox vs active control

Key facts

Study ID
NCT01112722
Run by
Apimeds, Inc.
People needed
363
Starts
2013-12-01
Expected to finish
2016-12-01
Last updated by the study team
2016-12-13

Who can join

Age: 30 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.